At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIAF bioAffinity Technologies, Inc.
Pre-Mkt 01-12 05:46:18 EST
1.33
+0.04
+3.10%
High1.37
Low1.30
Vol46.48K
Open1.31
D1 Closing1.29
Amplitude5.77%
Mkt Cap5.98M
Tradable Cap4.52M
Total Shares4.50M
T/O61.33K
T/O Rate1.37%
Tradable Shares3.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
bioAffinity Technologies’ Precision Pathology Laboratory Services Maintains CAP Accreditation
Wallachbeth Capital Announces the Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.